ReviewCureus2025
Assessment of Health-Related Quality of Life in Parkinson's Disease: A Systematic Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Psychometric properties of the Turkish version of the Parkinson's disease quality of life-7 (PDQoL-7) in older adults.BMC geriatrics · 2026Article
- Exploring the Impact of Parkinson's Disease on Marital Relationships.Nursing reports (Pavia, Italy) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Different studies conducted on the effects of Parkinson's Disease (PD) on the health-related quality of life (HRQoL) have presented contradictory outcomes, with the underlying domains of HRQoL requiring additional studies. Thus, the objective of this systematic review is to evaluate, by comparing and contrasting, the disease-specific HRQoL in PD. To attain the stated objective, a systematic review of various online databases, including PubMed, Scopus, Web of Science, Google Scholar, and MEDLINE, was conducted. Additionally, the study employed an increasingly robust methodology based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines and Cochrane guidelines. Therefore, the study's inclusion criteria required that only studies published between 2010 and 2025, as well as those published in the English language, were to be included. The quality of included studies was further assessed via an appraisal tool for cross-sectional studies. For this study, a total of 10 studies satisfied the inclusion criteria and were subsequently reviewed. The included studies disclosed that PD patients had significantly poorer HRQoL compared to healthy and non-PD persons, driven by both the motor and non-motor systems (pain, fatigue, depression), medication effects, disease progression, and cognitive/social decline, with increased severity being observed in female and younger patients. Nevertheless, the psychiatric comorbidity data remain inconsistent. Thus, in PD, HRQoL is significantly impaired by the motor and non-motor symptoms, disease progression, and psychosocial aspects that require multidisciplinary care, improved assessment tools, as well as targeted interventions to tackle the mental and physical health for better patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.